Patterns of treatment switching in multiple sclerosis therapies in US patients active on social media: Application of social media content analysis to health outcomes research

Journal of Medical Internet Research

Volumn 18, Issue 3, 2016, Pages

  Risson, Valéry ^a   Saini, Deepanshu ^b   Bonzani, Ian ^c   Huisman, Alice ^a   Olson, Melvin ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

^b IMS Health   (India)

^c IQVIA   (United States)

Author keywords

Drug switching; Internet; Multiple sclerosis; Outcomes assessment

Indexed keywords

ADULT; AGED; BLOGGING; DRUG SUBSTITUTION; FACTUAL DATABASE; FEMALE; HUMAN; INFORMATION PROCESSING; INTERNET; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; OUTCOME ASSESSMENT; QUESTIONNAIRE; SOCIAL MEDIA; UNITED STATES; YOUNG ADULT;

ADULT; AGED; BLOGGING; DATA COLLECTION; DATABASES, FACTUAL; DRUG SUBSTITUTION; FEMALE; HUMANS; INTERNET; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; OUTCOME ASSESSMENT, HEALTH CARE; SOCIAL MEDIA; SURVEYS AND QUESTIONNAIRES; UNITED STATES; YOUNG ADULT;

EID: 84962061620     PISSN: None     EISSN: 14388871     Source Type: Journal    
DOI: 10.2196/jmir.5409     Document Type: Article

References (29)

1. Cooper S. Fierce Healthcare. 2012 Nov 20. New study shows 72 percent of European online consumers are social health users URL: http://www.fiercehealthcare.com/press-releases/new-study-shows-72-percent-european-online-consumers-are-social-health-user [accessed 2016-02-22] [WebCite Cache ID 6fU4VuWHk]
2. Marrie RA, Salter AR, Tyry T, Fox RJ, Cutter GR. Preferred sources of health information in persons with multiple sclerosis: degree of trust and information sought. J Med Internet Res 2013;15(4):e67 [FREE Full text] [doi: 10.2196/jmir.2466] [Medline: 23635393]
3. Fox S, Duggan M. Health Online 2013. Washington DC: Pew Internet & American Life Project; 2013 Jan 15. URL: http://www.pewinternet.org/~/media//Files/Reports/PIP-HealthOnline.pdf [accessed 2016-02-22] [WebCite Cache ID 6dH1jDGTc]
4. Alshaikh F, Ramzan F, Rawaf S, Majeed A. Social network sites as a mode to collect health data: a systematic review. J Med Internet Res 2014;16(7):e171 [FREE Full text] [doi: 10.2196/jmir.3050] [Medline: 25048247]
5. Dawson J. New Media Age. 2010 Mar 25. Doctors join patients in going online for health information URL: http://connection. ebscohost.com/c/opinions/49259197/doctors-join-patients-going-online-health-information [accessed 2015-11-24] [WebCite Cache ID 6dH1pOdaS]
6. Health Research Institute. Social Media "Likes" Healthcare: From Marketing to Social Business. Delaware: PricewaterhouseCoopers LLP; 2012 Apr. URL: http://download.pwc.com/ie/pubs/2012-social-media-likes-healthcare.pdf [accessed 2016-03-03] [WebCite Cache ID 6fjVZvaeQ]
7. Eysenbach G. Infodemiology and infoveillance: framework for an emerging set of public health informatics methods to analyze search, communication and publication behavior on the Internet. J Med Internet Res 2009;11(1):e11 [FREE Full text] [doi: 10.2196/jmir.1157] [Medline: 19329408]
8. McNeil K, Brna PM, Gordon KE. Epilepsy in the Twitter era: a need to re-tweet the way we think about seizures. Epilepsy Behav 2012 Feb;23(2):127-130. [doi: 10.1016/j.yebeh.2011.10.020] [Medline: 22134096]
9. Cameron D, Smith GA, Daniulaityte R, Sheth AP, Dave D, Chen L, et al. PREDOSE: a semantic web platform for drug abuse epidemiology using social media. J Biomed Inform 2013 Dec;46(6):985-997 [FREE Full text] [doi: 10.1016/j.jbi.2013.07.007] [Medline: 23892295]
10. Freifeld CC, Brownstein JS, Menone CM, Bao W, Filice R, Kass-Hout T, et al. Digital drug safety surveillance: monitoring pharmaceutical products in twitter. Drug Saf 2014 May;37(5):343-350 [FREE Full text] [doi: 10.1007/s40264-014-0155-x] [Medline: 24777653]
11. Ramagopalan S, Wasiak R, Cox A. F1000Research. 2014. Using Twitter to investigate opinions about multiple sclerosis treatments: a descriptive, exploratory study URL: http://f1000research.com/articles/3-216/v1 [accessed 2015-11-24] [WebCite Cache ID 6dH1ts9cZ]
12. European Medicines Agency, Heads of Medicines Agencies. Guideline on Good Pharmacovigilance Practices (GVP). London: European Medicines Agency; 2014 Sep 16. Module VI - Management and reporting of adverse reactions to medicinal products (Rev 1) URL: http://www.ema.europa.eu/docs/en-GB/document-library/Scientific-guideline/2014/09/WC500172402.pdf [accessed 2016-02-22] [WebCite Cache ID 6dH1wplhB]
13. Epstein M, International Society of Pharmacoepidemiology. Guidelines for good pharmacoepidemiology practices (GPP). Pharmacoepidemiol Drug Saf 2005 Aug;14(8):589-595. [doi: 10.1002/pds.1082] [Medline: 15918159]
14. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. Int J Surg 2014 Dec;12(12):1495-1499 [FREE Full text] [doi: 10.1016/j.ijsu.2014.07.013] [Medline: 25046131]
15. World Medical Association. WMA Declaration of Helsinki - Ethical Principles for Medical Research Involving Human Subjects, amended by the 59th WMA General Assembly, Seoul, October 2008. 2016. URL: http://www.wma.net/en/30publications/10policies/b3/index.html.pdf [accessed 2015-11-24] [WebCite Cache ID 6dH1zuJlJ]
16. Noonan CW, Williamson DM, Henry JP, Indian R, Lynch SG, Neuberger JS, et al. The prevalence of multiple sclerosis in 3 US communities. Prev Chronic Dis 2010 Jan;7(1):A12 [FREE Full text] [Medline: 20040227]
17. Capkun G, Lahoz R, Verdun E, Song X, Chen W, Korn JR, et al. Expanding the use of administrative claims databases in conducting clinical real-world evidence studies in multiple sclerosis. Curr Med Res Opin 2015 May;31(5):1029-1039. [doi: 10.1185/03007995.2015.1014029] [Medline: 25661016]
18. Hay MC, Strathmann C, Lieber E, Wick K, Giesser B. Why patients go online: multiple sclerosis, the internet, and physician-patient communication. Neurologist 2008 Nov;14(6):374-381. [doi: 10.1097/NRL.0b013e31817709bb] [Medline: 19008743]
19. Burkell JA, Wolfe DL, Potter PJ, Jutai JW. Information needs and information sources of individuals living with spinal cord injury. Health Info Libr J 2006 Dec;23(4):257-265. [doi: 10.1111/j.1471-1842.2006.00686.x] [Medline: 17177946]
20. Harbo HF, Gold R, Tintoré M. Sex and gender issues in multiple sclerosis. Ther Adv Neurol Disord 2013 Jul;6(4):237-248 [FREE Full text] [doi: 10.1177/1756285613488434] [Medline: 23858327]
21. Ahlgren C, Odén A, Lycke J. High nationwide prevalence of multiple sclerosis in Sweden. Mult Scler 2011 Aug;17(8):901-908. [doi: 10.1177/1352458511403794] [Medline: 21459810]
22. Orton S, Herrera BM, Yee IM, Valdar W, Ramagopalan SV, Sadovnick AD, Canadian Collaborative Study Group. Sex ratio of multiple sclerosis in Canada: a longitudinal study. Lancet Neurol 2006 Nov;5(11):932-936. [doi: 10.1016/S1474-4422(06)70581-6] [Medline: 17052660]
23. Contasta I, Totaro R, Pellegrini P, Del BT, Carolei A, Berghella AM. A gender-related action of IFNbeta-therapy was found in multiple sclerosis. J Transl Med 2012;10:223 [FREE Full text] [doi: 10.1186/1479-5876-10-223] [Medline: 23148845]
24. Spelman T, Kalincik T, Zhang A, Pellegrini F, Wiendl H, Kappos L, et al. Comparative efficacy of switching to natalizumab in active multiple sclerosis. Ann Clin Transl Neurol 2015 Apr;2(4):373-387 [FREE Full text] [doi: 10.1002/acn3.180] [Medline: 25909083]
25. Melzer N, Meuth SG. Disease-modifying therapy in multiple sclerosis and chronic inflammatory demyelinating polyradiculoneuropathy: common and divergent current and future strategies. Clin Exp Immunol 2014 Mar;175(3):359-372 [FREE Full text] [doi: 10.1111/cei.12195] [Medline: 24032475]
26. Alpers GW, Winzelberg AJ, Classen C, Roberts H, Dev P, Koopman C, et al. Evaluation of computerized text analysis in an Internet breast cancer support group. Comput Hum Behav 2005 Mar;21(2):361-376. [doi: 10.1016/j.chb.2004.02.008]
27. Bantum EO, Owen JE. Evaluating the validity of computerized content analysis programs for identification of emotional expression in cancer narratives. Psychol Assess 2009 Mar;21(1):79-88. [doi: 10.1037/a0014643] [Medline: 19290768]
28. Goff DA, Kullar R, Newland JG. Review of Twitter for infectious diseases clinicians: useful or a waste of time? Clin Infect Dis 2015 May 15;60(10):1533-1540. [doi: 10.1093/cid/civ071] [Medline: 25652087]
29. Chary M, Genes N, McKenzie A, Manini AF. Leveraging social networks for toxicovigilance. J Med Toxicol 2013 Jun;9(2):184-191 [FREE Full text] [doi: 10.1007/s13181-013-0299-6] [Medline: 23619711]